A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Care Dx, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 712 shares of CDNA stock, worth $11,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
712
Previous 598 19.06%
Holding current value
$11,349
Previous $12,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$11.57 - $20.63 $1,318 - $2,351
114 Added 19.06%
712 $10,000
Q2 2025

Aug 05, 2025

BUY
$14.18 - $20.08 $8,479 - $12,007
598 New
598 $12,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $852M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.